MiNDERA Corporation

About:

MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases.

Top Investors: Mountain Group Capital, MedTech Innovator, Scientific Health Development Partners, Primer Capital, Rockmont Investments

Description:

MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases. The company is currently focused on a technology solution to extract skin biomarkers in a non-invasive manner. It was founded in 2013 and is based in San Francisco, United States.

Total Funding Amount:

$34.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2013-12-01

Contact Email:

info(AT)minderadx.com

Founders:

Philippe Nore, Tahir Mahmood, Tobin Dickerson

Number of Employees:

11-50

Last Funding Date:

2024-07-31

IPO Status:

Private

Industries: